Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Featured News

    Ebola Survivors: New Study Yields Clues

    By Global Biodefense StaffJune 30, 2016
    Ebola Outbreak Research and Analysis
    Share
    Facebook LinkedIn Reddit Email

    Ebola Outbreak Research and AnalysisA first-of-its-kind Ebola study by researchers at Centers for Disease Control and Prevention (CDC), Emory University School of Medicine, and University of Nebraska Medical Center has revealed clues as to how some people are able to survive the deadly virus.

    The researchers used samples from Ebola patients treated in the United States taken both during their illness and recovery to analyze immune responses. In the seven U.S. patients, researchers tracked 54 different markers of immune-system activity from hospital admission until the day of discharge.

    Read also: Quantum Dots Light the Way for New Ebola and HIV Treatment

    Among the seven patients, five had moderate Ebola virus disease (EVD) and two had severe EVD requiring mechanical ventilation and dialysis.

    The results show patients with severe EVD had high levels of virus in their blood and out-of-control immune responses leading to destruction of healthy tissues, multisystem organ failure, shock, and, in most cases, death. In contrast, patients with moderate EVD had strong, healthy immune responses that were able to control the virus. All of the patients with moderate illness and one patient with severe illness survived.

    This is the first time researchers have been able to study EVD in this manner. “We were able to identify the particular components of patients’ immune systems that successfully fought off the virus,” said lead author Anita McElroy, M.D., Ph.D., who is a guest researcher in CDC’s Viral Special Pathogens Branch and an Emory physician and faculty member. “These are the parts of the immune system that we need to tap into to develop new therapies.”

    Read also: Positive Data for Janssen, Bavarian Nordic Ebola Vaccine Regimen

    It is unclear why exactly some people’s immune systems respond more effectively to viruses. Possible contributing factors include genetics and whether or not a person has other illnesses or conditions. Identifying which parts of the immune system malfunction in severe EVD cases as well as the parts that function well in the moderate cases could lead to the design of therapies that might theoretically inhibit the disease’s progression.

    Ebola virus causes a severe and often fatal infection that can include fever, diarrhea and unexplained bleeding. Despite the fact that more than 30,000 individuals have acquired EVD since it was discovered in 1976, the medical and scientific community still does not have a clear understanding of the mechanisms by which Ebola causes such severe illness.

    Read more: Kinetic Analysis of Biomarkers in a Cohort of US Patients with Ebola Virus Disease.

    Biomarkers Ebola Emerging Threats Immune Response
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleBattelle Awarded 10.1M CBRN Support Contract
    Next Article UTHealth Awarded 11M to Study Deadly Prions

    Related Stories

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Biomarkers for Detection of Exposure to Nitrogen Mustards

    September 20, 2023

    The Basics on the Nipah Virus Outbreak in India

    September 19, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.